Epidemiological and virological characteristics of people living with HIV on antiretroviral treatment for more than 6 months in virological failure in Brazzaville, Republic of Congo.

Virological failure is one of the main causes of failing to treat, and better management of HIV infection requires understanding and controlling the factors that contribute to this phenomenon. The main objective was to characterize the patients of the active file of the Brazzaville Outpatient Treatment Center in virological failure to identify predictive factors leading to virological failure. Conducted between June and December 2020, this was a cross-sectional study.

Absence of Resistance Mutations in the Integrase Coding Region among ART-Experienced Patients in the Republic of the Congo.

Background: HIV infects around one hundred thousand patients in the Republic of the Congo. Approximately 25% of them receive an antiretroviral treatment; current first-line regimens include two NRTIs and one NNRTI, reverse transcriptase inhibitors. Recently, protease inhibitors (PIs) were also introduced as second-line therapy upon clinical signs of treatment failure.

[Corticotherapy in the otorhinolaryngology service at Brazzaville university hospital].

Corticoids are one of the great therapeutic advances of modern medicine. A retrospective study of corticotherapy conducted in the otorhinolaryngology and cervicofacial surgery service at Brazzaville University Hospital (Centre hospitalier et universitaire de Brazzaville) examined 952 cases treated from 1996 through 2000 and enabled us to determine that: corticoids account for 14% of the treatments prescribed to ENT patients; the patients' average age was 27 years; the most common indications were infections and/or inflammatory disorders (98.2%); local administration was most often prescribed (78.